| Detected | Trial | Change |
|---|---|---|
| 2026-05-21 | NCT06898957 Study of Tarlatamab in Combination With YL201 With or Without Anti-programmed Death… |
Enrollment reduced: 200 -> 29 participants |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT07487896 | A Study of YL201 Versus Investigator's Choice of Chemotherapy in Participants With… | Advanced Esophageal Squamous Cell Carcinoma | Not Yet Recruiting |
| NCT06612151 | A Phase III Study of YL201 in Relapsed Small Cell Lung Cancer | Small Cell Lung Cancer | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT07407933 | A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With… | Thoracic Neoplasms, Lung Diseases, Small Cell Lung Carcinoma | Recruiting |
| Phase 1 | |||
| NCT06898957 | Study of Tarlatamab in Combination With YL201 With or Without Anti-programmed Death… | Small Cell Lung Cancer | Active, Not Recruiting |